Ishii H - Search Results

1

Reprogramming of gastrointestinal cancer cells.

Dewi D, Ishii H, Haraguchi N, Nishikawa S, Kano Y, Fukusumi T, Ohta K, Miyazaki S, Ozaki M, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. Dewi D, et al. Among authors: ishii h. Cancer Sci. 2012 Mar;103(3):393-9. doi: 10.1111/j.1349-7006.2011.02184.x. Epub 2012 Jan 17. Cancer Sci. 2012. PMID: 22151786 Free PMC article. Review.

2

INI-1, a partner gene of ALL-1, is highly conserved in human acute leukemia.

Mimori K, Inoue H, Ishii H, Mori M. Mimori K, et al. Among authors: ishii h. Oncol Rep. 2003 May-Jun;10(3):551-3. Oncol Rep. 2003. PMID: 12684622

3

Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.

Ishii H, Mimori K, Vecchione A, Sutheesophon K, Fujiwara T, Mori M, Furukawa Y. Ishii H, et al. Biochem Biophys Res Commun. 2004 Apr 16;316(4):1088-93. doi: 10.1016/j.bbrc.2004.02.159. Biochem Biophys Res Commun. 2004. PMID: 15044096

4

Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.

Mimori K, Ueo H, Kuroki T, Shiraishi T, Creer S, Taylor S, Ishii H, Mori M. Mimori K, et al. Among authors: ishii h. Oncol Rep. 2004 Jul;12(1):19-23. Oncol Rep. 2004. PMID: 15201953

5

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.

Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M. Mimori K, et al. Among authors: ishii h. Clin Cancer Res. 2004 Dec 15;10(24):8243-9. doi: 10.1158/1078-0432.CCR-04-0849. Clin Cancer Res. 2004. PMID: 15623600

6

Differential roles of E-type cyclins during transformation of murine E2F-1-deficient cells.

Ishii H, Mimori K, Yoshikawa Y, Mori M, Furukawa Y, Vecchione A. Ishii H, et al. DNA Cell Biol. 2005 Mar;24(3):173-9. doi: 10.1089/dna.2005.24.173. DNA Cell Biol. 2005. PMID: 15767783

7

Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.

Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y. Ishii H, et al. Mol Cancer Res. 2005 Mar;3(3):130-8. doi: 10.1158/1541-7786.MCR-04-0209. Mol Cancer Res. 2005. PMID: 15798093 Free article.

8

Differentially expressed genes in endothelial differentiation.

Ishii H, Mimori K, Mori M, Vecchione A. Ishii H, et al. DNA Cell Biol. 2005 Jul;24(7):432-7. doi: 10.1089/dna.2005.24.432. DNA Cell Biol. 2005. PMID: 16008511

9

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M. Mimori K, et al. Among authors: ishii h. Cancer Res. 2006 Mar 1;66(5):2683-90. doi: 10.1158/0008-5472.CAN-05-2509. Cancer Res. 2006. PMID: 16510588

10

Fhit modulates the DNA damage checkpoint response.

Ishii H, Mimori K, Inoue H, Inageta T, Ishikawa K, Semba S, Druck T, Trapasso F, Tani K, Vecchione A, Croce CM, Mori M, Huebner K. Ishii H, et al. Cancer Res. 2006 Dec 1;66(23):11287-92. doi: 10.1158/0008-5472.CAN-06-2503. Cancer Res. 2006. PMID: 17145874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,093 results

Search Page